PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of procrsmedFormerly medchtJournal of the Royal Society of MedicineProceedings of the Royal Society of Medicine
 
Proc R Soc Med. 1977; 70(Suppl 5): 40–44.
PMCID: PMC1542839

Problems with Beta Adrenergic Blocking Drugs and other Antihypertensive Drugs

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (758K), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Ahlmark G, Saetre H, Korsgren M. Letter: Reduction of sudden Deaths after myocardial infarction. Lancet. 1974 Dec 28;2(7896):1563–1563. [PubMed]
  • Amsterdam EA, Gorlin R, Wolfson S. Evaluation of long-term use of propranolol in angina pectoris. JAMA. 1969 Oct 6;210(1):103–106. [PubMed]
  • APTHORP GH, CHAMBERLAIN DA, HAYWARD GW. THE EFFECTS OF SYMPATHECTOMY ON THE ELECTROCARDIOGRAM AND EFFORT TOLERANCE IN ANGINA PECTORIS. Br Heart J. 1964 Mar;26:218–226. [PMC free article] [PubMed]
  • Beumer HM. Adverse effects of beta-adrenergic receptor blocking drugs on respiratory function. Drugs. 1974;7(1):130–138. [PubMed]
  • Grüneberg RN, Leigh DA, Brumfitt W. Relationship of bacteriuria in pregnancy to acute pyelonephritis, prematurity, and fetal mortality. Lancet. 1969 Jul 5;2(7610):1–3. [PubMed]
  • Coltart DJ, Gibson DG, Shand DG. Plasma propranolol levels associated with suppression of ventricular ectopic beats. Br Med J. 1971 Feb 27;1(5747):490–491. [PMC free article] [PubMed]
  • Davidov M, Kakaviatos N, Finnerty FA., Jr The antihypertensive effects of an imidazoline compound. Clin Pharmacol Ther. 1967 Nov-Dec;8(6):810–816. [PubMed]
  • Dintenfass L, Lake R. Letter: Beta blocker and blood viscosity. Lancet. 1976 May 8;1(7967):1026–1026. [PubMed]
  • Eliasch H, Rosén A, Scott HM. Systemic circulatory response to stress of simulated flight and to physical exercise before and after propranolol blockade. Br Heart J. 1967 Sep;29(5):671–683. [PMC free article] [PubMed]
  • Finch L, Haeusler G. Further evidence for a central hypotensive action of alpha-methyldopa in both the rat and cat. Br J Pharmacol. 1973 Feb;47(2):217–228. [PMC free article] [PubMed]
  • Forrest WA. A total of 254 cases of angina pectoris treated with oxprenolol in hospital practice--a monitored release study. Br J Clin Pract. 1972 May;26(5):217–222. [PubMed]
  • Fox KM, Chopra MP, Portal RW, Aber CP. Long-term beta blockade: possible protection from myocardial infarction. Br Med J. 1975 Jan 18;1(5950):117–119. [PMC free article] [PubMed]
  • Frishman WH, Weksler B, Christodoulou JP, Smithen C, Killip T. Reversal of abnormal platelet aggregability and change in exercise tolerance in patients with angina pectoris following oral propranolol. Circulation. 1974 Nov;50(5):887–896. [PubMed]
  • Greenblatt DJ, Koch-Weser J. Adverse reactions to beta-adrenergic receptor blocking drugs: a report from the Boston collaborative drug surveillance program. Drugs. 1974;7(1):118–129. [PubMed]
  • Heffernan A, Carty A, O'Malley K, Bugler J. A within-patient comparison of debrisoquine and methyldopa in hypertension. Br Med J. 1971 Jan 9;1(5740):75–78. [PMC free article] [PubMed]
  • Henning M, Rubenson A. Evidence that the hypotensive action of methyldopa is mediated by central actions of methylnoradrenaline. J Pharm Pharmacol. 1971 Jun;23(6):407–411. [PubMed]
  • Hjalmarson A, Waagstein F, Waldenström A. Proceedings: Effects of cardioselective beta-blockers on chest pain, ECG, and heart function in acute myocardial infarction. Br Heart J. 1976 May;38(5):530–531. [PubMed]
  • Hunyor SN, Hansson L, Harrison TS, Hoobler SW. Effects of clonidine withdrawal: possible mechanisms and suggestions for management. Br Med J. 1973 Apr 28;2(5860):209–211. [PMC free article] [PubMed]
  • Ingram GI, Jones RV. The rise in clotting factor 8 induced in man by adrenaline: effect of alpha- and beta-blockers. J Physiol. 1966 Nov;187(2):447–454. [PubMed]
  • Johnson P, Kitchin AH, Lowther CP, Turner RW. Treatment of hypertension with methyldopa. Br Med J. 1966 Jan 15;1(5480):133–137. [PMC free article] [PubMed]
  • de Grouchy J. Human chromosomes and their anomalies. Postgrad Med J. 1976;52 (Suppl 2):5–16. [PubMed]
  • Lund-Larsen G, Sivertssen E. Hemodynamic effects of propranolol (Inderal) and H 56-28 (Aptin) in patients with acute myocardial infarction. A comparative study. Acta Med Scand. 1969 Sep;186(3):187–191. [PubMed]
  • Lyon LJ, Nevins MA. Alprenolol treatment of angina pectoris. JAMA. 1971 Mar 8;215(10):1669–1669. [PubMed]
  • Maroko PR, Kjekshus JK, Sobel BE, Watanabe T, Covell JW, Ross J, Jr, Braunwald E. Factors influencing infarct size following experimental coronary artery occlusions. Circulation. 1971 Jan;43(1):67–82. [PubMed]
  • Oates JA, Seligmann AW, Clark MA, Rousseau P, Lee RE. The relative efficacy of guanethidine, methyldopa and pargyline as antihypertensive agents. N Engl J Med. 1965 Sep 30;273(14):729–734. [PubMed]
  • Onesti G, Schwartz AB, Kim KE, Paz-Martinez V, Swartz C. Antihypertensive effect of clonidine. Circ Res. 1971 May;28(5 Suppl):53–69. [PubMed]
  • Pelides LJ, Reid DS, Thomas M, Shillingford JP. Inhibition by -blockade of the ST segment elevation after acute myocardial infarction in man. Cardiovasc Res. 1972 May;6(3):295–301. [PubMed]
  • Prichard BN. Beta-adrenergic receptor blocking drugs in angina pectoris. Drugs. 1974;7(1):55–84. [PubMed]
  • PRICHARD BN, GILLAM PM. USE OF PROPRANOLOL (INDERAL) IN TREATMENT OF HYPERTENSION. Br Med J. 1964 Sep 19;2(5411):725–727. [PMC free article] [PubMed]
  • Prichard BN, Gillam PM, Graham BR. Beta receptor antagonism in hypertension; comparison with the effect of adrenergic neurone inhibition on cardiovascular responses. Int Z Klin Pharmakol Ther Toxikol. 1970 Dec;4(1):131–140. [PubMed]
  • Prichard BN, Johnston AW, Hill ID, Rosenheim ML. Bethanidine, Guanethidine, and Methyldopa in Treatment of Hypertension: a Within-patient Comparison. Br Med J. 1968 Jan 20;1(5585):135–144. [PMC free article] [PubMed]
  • Raftos J, Bauer GE, Lewis RG, Stokes GS, Mitchell AS, Young AA, Maclachlan I. Clonidine in the treatment of severe hypertension. Med J Aust. 1973 Apr 21;1(16):786–793. [PubMed]
  • Shinebourne E, Fleming J, Hamer J. Effects of beta-adrenergic blockade during exercise in hypertensive and ischaemic heart-disease. Lancet. 1967 Dec 9;2(7528):1217–1220. [PubMed]
  • Simpson FO. Beta-adrenergic receptor blocking drugs in hypertension. Drugs. 1974;7(1):85–105. [PubMed]
  • Taggart P, Carruthers M. Suppression by oxprenolol of adrenergic response to stress. Lancet. 1972 Aug 5;2(7771):256–258. [PubMed]
  • Taggart P, Carruthers M, Somerville W. Electrocardiogram, plasma catecholamines and lipids, and their modification by oxyprenolol when speaking before an audience. Lancet. 1973 Aug 18;2(7825):341–346. [PubMed]
  • Waal-Manning HJ, Simpson FO. Practolol treatment in asthmatics. Lancet. 1971 Dec 4;2(7736):1264–1265. [PubMed]
  • Whittington-Coleman PJ, Carrier O, Jr, Douglas BH. The effects of propranolol on cholesterol-induced atheromatous lesions. Atherosclerosis. 1973 Sep-Oct;18(2):337–345. [PubMed]
  • Wilhelmsson C, Vedin JA, Wilhelmsen L, Tibblin G, Werkö L. Reduction of sudden deaths after myocardial infarction by treatment with alprenolol. Preliminary results. Lancet. 1974 Nov 16;2(7890):1157–1160. [PubMed]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press